[1]
Jenkins, S. M.; Wadsworth, H. J.; Bromidge, S.; Orlek, B. S.; Wyman, P. A.; Riley, G. J.; Hawkins, J. Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands. J. Med. Chem. 1992, 35, 2392–2406.CrossrefGoogle Scholar
[2]
Chen, C.; Dagnino, R.; Huang, C. Q.; McCarthy, J. R.; Grigoriadis, D. E. 1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: novel synthesis via cyclization of N-acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-releasing factor-1 (CRF1) receptor antagonist activities. Bioorg. Med. Chem. Lett. 2001, 11, 3165–3168.Web of ScienceCrossrefGoogle Scholar
[3]
Tully, W. R.; Gardner, C. R.; Gillepsie, R. J.; Westwood, R. 2-(Oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors. J. Med. Chem. 1991, 34, 2060–2067.CrossrefGoogle Scholar
[4]
Burrell, G.; Evans, J. M.; Hadley, M. S.; Hicks, F.; Stemp, G. Benzopyran potassium channel activators related to cromakalim – heterocyclic amide replacements at position. Bioorg. Med. Chem. Lett. 1994, 4, 1285–1290.CrossrefGoogle Scholar
[5]
Boyd, S. A.; Fung, A. K. L.; Baker, W. R.; Mantei, R. A.; Stein, H. H.; Cohen, J.; Barlow, J. L.; Klinghofer, V.; Wessale, J. L.; Verburg, K. M.; et al. Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dog. J. Med. Chem. 1994, 37, 2991–3007.CrossrefGoogle Scholar
[6]
Duncia, J. V.; Santela, J. B., III; Higley, A.; Van Atten, M. K.; Weber, P. C.; Alexander, R. S.; Kettner, C. A.; Pruitt, J. R.; Liauw, A. Y.; Quan, M. L.; et al. Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 775–780.CrossrefGoogle Scholar
[7]
Ghorab, M. M.; El-Sharief, A. M. Sh.; Ammar, Y. A.; Mohamed, Sh. I. Synthesis and radiation stability of novel biologically active sulfur compounds derived from 1,2-bis(4-amino-5-mercapto-s-triazol-3-yl)ethane. Il Farmaco 2000, 55, 354–361.CrossrefGoogle Scholar
[8]
Chen, X.; Liu, R.; Xu, Y.; Zou G. Tunable protic ionic liquids as solvent-catalysts for improved synthesis of multiply substituted 1,2,4-triazoles from oxadiazoles and organoamines. Tetrahedron 2012, 68, 4813–4819.Web of ScienceCrossrefGoogle Scholar
[9]
Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S.; Bodaghi Fard, M. A.; Moghanian, M. A simple and efficient procedure for synthesis of optically active 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives containing L-amino acid moieties. J. Chin. Chem. Soc. 2009, 56, 1043–1047.Google Scholar
[10]
Foroughifar, N.; Ebrahimi, S.; Mobinikhaledi, A.; Mozafari R. An efficient and convenient protocol for the synthesis of optically active [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives containing L-amino acid moieties. Heterocycl. Commun. 2011, 17, 211–214.Web of ScienceGoogle Scholar
[11]
Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S.; Kamali, M.; Kazemi, M. A simple and efficient procedure for synthesis of optically active 1,2-bis(s-triazolo)bis(s-triazolo[3,4-b][1,3,4]thiadiazole-3-yl) alkane derivatives containing L-amino acid moieties. J. Sulfur Chem. 2011, 32, 593–598.Web of ScienceCrossrefGoogle Scholar
[12]
Foroughifar, N.; Ebrahimi, S.; Mobinikhaledi, A.; Mozafari, R. An efficient and convenient protocol for the synthesis of optically active 1,2,4-triazolo-[3,4-b]-[1,3,4]-thiadiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives having L-amino acid moieties. S. Afr. J. Chem. 2012, 65, 1–4.Google Scholar
[13]
Subrahmanya Bhat, K.; Poojary, B.; Jagadeesh Prasad, D.; Naik, P.; Shivarama Holla, B. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety. Eur. J. Med. Chem. 2009, 44, 5066–5070.Google Scholar
[14]
Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S. An efficient and convenient protocol for the synthesis of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines. Synthetic Commun. 2010, 40, 2421–2428.CrossrefGoogle Scholar
[15]
Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S.; Moghanian, H.; Bodaghi Fard, M. A.; Kalhor, M. Synthesis of a new class of azathia crown macrocycles containing two 1,2,4-triazole or two 1,3,4-thiadiazole rings as subunits. Tetrahedron Lett. 2009, 50, 836–839.CrossrefGoogle Scholar
[16]
Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S. Synthesis of a novel class of aza crown macrocycles and lariat crown ethers containing two 1,2,4-triazole rings as subunits. Synthesis 2009, 15, 2557–2560.Google Scholar
[17]
Ebrahimi, S.; Moghanian H. Synthesis of new aza crown macrocycles and lariat ethers. Heterocycl. Commun. 2012, 18, 29–31.Web of ScienceGoogle Scholar
[18]
Almajan, G. L.; Barbuceanu, S. F.; Saramet, I.; Draghici C. New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation. Eur. J. Med. Chem. 2010, 45, 3191–3195.Google Scholar
[19]
Kishimoto, Y.; Akabori, Y.; Horiguchi, T. (Methylene)dithiodiacetic acid derivatives. I. Antimicrobial and antiprotozoal activity 1. Yakugaku Zasshi 1958, 78, 447–450.Google Scholar
[20]
Ritter, J. J.; Lover, M. J. Mercaptocarboxylic acids as reagents for the identification of carbonyl compound. J. Am. Chem. Soc. 1952, 74, 5576–5577.CrossrefGoogle Scholar
[21]
Stoner, G. G.; Dougherty, G. The use of bunte salts in synthesis. II. The preparation of derivatives of mercapto aliphatic acids. J. Am. Chem. Soc. 1941, 63, 987–988.CrossrefGoogle Scholar
Comments (0)